| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Ihs Health Group is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Arsenal Medical is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Care Financing Administration is a Gwynn Oak, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Avondale Care Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.